Skip to main content
Hit enter to search or ESC to close
Close Search
Hepion PharmaceuticalsHepion Pharmaceuticals
Menu
  • About
    • Leadership
    • Board of Directors
  • Portfolio
    • Hepatocellular Carcinoma
    • Gravitas Life Sciences
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    Hepion Pharmaceuticals

    Hepatitis Quest Moves From C to B Under Ex-Gilead Leaders [via Bloomberg Business]

    http://www.bloomberg.com/news/articles/2015-02-04/hepatitis-quest-moves-from-c-to-b-under-former-gilead-executives

    Hepion Obtains HBV Candidate, Investment from Chimerix

    http://www.biocentury.com/dailynews/company/2014-12-18/contravir-obtains-hbv-candidate-investment-from-chimerix
    • Previous
    • 1
    • 2
    • 3
    About
    Newsroom
    Investors
    Contact
    Subscribe for Updates

    © 2026 Hepion Pharmaceuticals | Disclaimer & Terms of Use

    Close Menu
    • About
      • Leadership
      • Board of Directors
    • Portfolio
      • Hepatocellular Carcinoma
      • Gravitas Life Sciences
    • Newsroom
    • Investors
      • Investor Overview
      • Press Releases
      • Presentations
      • Stock Information
      • SEC Filings
      • Corporate Governance
    • Contact